
| September 26, 2026 | December 31, 2025 | |||||||||||||
| Assets | ||||||||||||||
| Current assets | ||||||||||||||
| Cash and cash equivalents | $ | 236,250 | $ | 329,648 | ||||||||||
| Short-term investments | 239,186 | 69,462 | ||||||||||||
Accounts receivable, net of allowances of $1,456 and $1,931, respectively | 138,940 | 280,161 | ||||||||||||
| Inventories, net | 245,493 | 210,739 | ||||||||||||
| Prepaid expenses | 16,831 | 19,500 | ||||||||||||
| Income tax receivable | — | 656 | ||||||||||||
| Other current assets | 31,598 | 41,080 | ||||||||||||
| Total current assets | 908,298 | 951,246 | ||||||||||||
Property, plant, and equipment, net of accumulated depreciation of $140,079 and $125,807, respectively | 172,292 | 164,560 | ||||||||||||
| Goodwill | 948,466 | 951,197 | ||||||||||||
| Trademark | 736,000 | 736,000 | ||||||||||||
| Customer relationships, net | 162,652 | 178,126 | ||||||||||||
| Other intangibles, net | 80,202 | 88,899 | ||||||||||||
| Other non-current assets | 88,685 | 80,956 | ||||||||||||
| Total assets | $ | 3,096,595 | $ | 3,150,984 | ||||||||||
Liabilities and Stockholders’ Equity | ||||||||||||||
| Current liabilities | ||||||||||||||
| Current portion of long-term debt | $ | 10,840 | $ | 13,261 | ||||||||||
| Accounts payable | 76,449 | 77,007 | ||||||||||||
| Accrued expenses and other liabilities | 181,437 | 224,222 | ||||||||||||
| Income taxes payable | 4,280 | 8,754 | ||||||||||||
| Total current liabilities | 273,006 | 323,244 | ||||||||||||
| Long-term debt, net | 945,554 | 943,547 | ||||||||||||
| Deferred tax liabilities, net | 225,643 | 227,449 | ||||||||||||
| Other non-current liabilities | 64,286 | 63,736 | ||||||||||||
| Total liabilities | 1,508,489 | 1,557,976 | ||||||||||||
Stockholders’ equity | ||||||||||||||
Preferred stock, $0.001 par value, 100,000,000 authorized, no shares issued or outstanding as of September 26, 2026 and December 31, 2025 | — | — | ||||||||||||
Common stock $0.001 par value, 750,000,000 authorized; 247,732,447 issued and 211,002,644 outstanding at September 26, 2026; 246,272,783 issued and 217,356,414 outstanding at December 31, 2025 | 248 | 247 | ||||||||||||
| Additional paid-in capital | 1,123,231 | 1,109,522 | ||||||||||||
Common stock in treasury; 36,729,803 and 28,916,369 at September 26, 2026 and December 31, 2025, respectively | (481,176) | (363,182) | ||||||||||||
| Retained earnings | 952,529 | 851,134 | ||||||||||||
Accumulated other comprehensive loss | (6,726) | (4,713) | ||||||||||||
Total stockholders’ equity | 1,588,106 | 1,593,008 | ||||||||||||
Total liabilities and stockholders’ equity | $ | 3,096,595 | $ | 3,150,984 | ||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||||||
| Net sales | $ | 260,134 | $ | 244,336 | $ | 833,728 | $ | 772,780 | ||||||||||||||||||
| Cost of sales | 135,484 | 127,635 | 435,326 | 403,372 | ||||||||||||||||||||||
| Gross profit | 124,650 | 116,701 | 398,402 | 369,408 | ||||||||||||||||||||||
| Selling, general and administrative expense | 59,449 | 61,368 | 186,307 | 179,871 | ||||||||||||||||||||||
| Research, development and engineering expense | 8,635 | 7,122 | 23,063 | 19,236 | ||||||||||||||||||||||
| Acquisition and restructuring related expense | 8 | 276 | 1,261 | 3,767 | ||||||||||||||||||||||
| Amortization of intangible assets | 6,355 | 6,882 | 19,082 | 20,587 | ||||||||||||||||||||||
| Operating income | 50,203 | 41,053 | 168,689 | 145,947 | ||||||||||||||||||||||
| Interest expense, net | 7,921 | 11,316 | 36,409 | 38,617 | ||||||||||||||||||||||
| Loss on debt extinguishment | — | — | 2,037 | — | ||||||||||||||||||||||
| Other expense (income), net | 1,141 | (1,469) | (273) | (1,996) | ||||||||||||||||||||||
| Total other expense | 9,062 | 9,847 | 38,173 | 36,621 | ||||||||||||||||||||||
| Income from operations before income taxes | 41,141 | 31,206 | 130,516 | 109,326 | ||||||||||||||||||||||
| Provision for income taxes | 8,722 | 7,178 | 29,121 | 26,166 | ||||||||||||||||||||||
| Net income | $ | 32,419 | $ | 24,028 | $ | 101,395 | $ | 83,160 | ||||||||||||||||||
| Earnings per share | ||||||||||||||||||||||||||
| Basic | $ | 0.15 | $ | 0.11 | $ | 0.47 | $ | 0.38 | ||||||||||||||||||
| Diluted | $ | 0.15 | $ | 0.11 | $ | 0.46 | $ | 0.37 | ||||||||||||||||||
| Weighted average common shares outstanding | ||||||||||||||||||||||||||
| Basic | 212,209,178 | 216,826,626 | 215,276,635 | 216,395,032 | ||||||||||||||||||||||
| Diluted | 216,531,281 | 222,420,881 | 219,897,633 | 222,074,267 | ||||||||||||||||||||||
Hayward Holdings, Inc. Unaudited Condensed Consolidated Statements of Cash Flows (Dollars in thousands) | Nine Months Ended | |||||||||||||
| September 26, 2026 | September 27, 2025 | |||||||||||||
| Cash flows from operating activities | ||||||||||||||
| Net income | $ | 101,395 | $ | 83,160 | ||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities | ||||||||||||||
| Depreciation | 17,915 | 17,026 | ||||||||||||
| Amortization of intangible assets | 24,668 | 25,808 | ||||||||||||
| Amortization of deferred debt issuance fees | 2,178 | 2,818 | ||||||||||||
| Stock-based compensation | 11,466 | 9,821 | ||||||||||||
| Deferred income taxes (benefit) | (2,735) | 1,949 | ||||||||||||
| Allowance for credit losses | (485) | (1,021) | ||||||||||||
| Loss on debt extinguishment | 1,836 | — | ||||||||||||
| Loss on sale/disposal of property, plant and equipment | 1,144 | 381 | ||||||||||||
| Other non-cash items | (2,650) | — | ||||||||||||
| Changes in operating assets and liabilities | ||||||||||||||
| Accounts receivable | 140,160 | 168,754 | ||||||||||||
| Inventories | (35,824) | (8,064) | ||||||||||||
| Other current and non-current assets | 14,245 | 29,913 | ||||||||||||
| Accounts payable | (508) | (14,002) | ||||||||||||
| Accrued expenses and other liabilities | (47,350) | (33,566) | ||||||||||||
| Net cash provided by operating activities | 225,455 | 282,977 | ||||||||||||
| Cash flows from investing activities | ||||||||||||||
| Purchases of property, plant, and equipment | (28,345) | (19,822) | ||||||||||||
| Software development costs | (924) | (1,579) | ||||||||||||
| Purchases of short-term investments | (362,501) | (19,650) | ||||||||||||
| Proceeds from short-term investments | 195,000 | — | ||||||||||||
| Net cash used in investing activities | (196,770) | (41,051) | ||||||||||||
| Cash flows from financing activities | ||||||||||||||
| Proceeds from issuance of long-term debt | 354,603 | — | ||||||||||||
| Payments of long-term debt | (353,429) | (6,941) | ||||||||||||
| Payments of short-term notes payable | — | (2,169) | ||||||||||||
| Debt issuance costs | (6,840) | (1,388) | ||||||||||||
| Purchase of common stock | (115,313) | — | ||||||||||||
| Proceeds from issuance of common stock | 2,243 | 1,729 | ||||||||||||
| Taxes paid for net share settlement of equity awards | (1,720) | (1,141) | ||||||||||||
| Other, net | (1,020) | (1,010) | ||||||||||||
| Net cash used in financing activities | (121,476) | (10,920) | ||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | (607) | 1,089 | ||||||||||||
| Change in cash and cash equivalents | (93,398) | 232,095 | ||||||||||||
| Cash and cash equivalents, beginning of period | 329,648 | 196,589 | ||||||||||||
| Cash and cash equivalents, end of period | $ | 236,250 | $ | 428,684 | ||||||||||
| Supplemental disclosures of cash flow information: | ||||||||||||||
| Cash paid-interest | $ | 39,481 | $ | 39,892 | ||||||||||
| Cash paid-income taxes, net of refunds | 34,718 | 20,587 | ||||||||||||
| Non-cash investing and financing activities: | ||||||||||||||
Accrued and unpaid purchases of property, plant, and equipment | $ | 1,867 | $ | 1,064 | ||||||||||
| Equipment financed under finance leases | 631 | 1,866 | ||||||||||||
| Refinancing of long-term debt | 605,397 | — | ||||||||||||
| (Dollars in thousands) | Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
| September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||||||
| Net income | $ | 32,419 | $ | 24,028 | $ | 101,395 | $ | 83,160 | ||||||||||||||||||
| Depreciation | 6,053 | 5,509 | 17,915 | 17,026 | ||||||||||||||||||||||
| Amortization | 8,240 | 8,642 | 24,668 | 25,808 | ||||||||||||||||||||||
| Interest expense, net | 7,921 | 11,316 | 36,409 | 38,617 | ||||||||||||||||||||||
| Income taxes | 8,722 | 7,178 | 29,121 | 26,166 | ||||||||||||||||||||||
| EBITDA | 63,355 | 56,673 | 209,508 | 190,777 | ||||||||||||||||||||||
Loss on debt extinguishment (a) | — | — | 2,037 | — | ||||||||||||||||||||||
Stock-based compensation (b) | — | — | — | 57 | ||||||||||||||||||||||
Currency exchange items (c) | 949 | (536) | 368 | 236 | ||||||||||||||||||||||
Acquisition and restructuring related expense, net (d) | 8 | 276 | 1,261 | 3,767 | ||||||||||||||||||||||
Other (e) | 203 | 2,653 | 437 | 1,567 | ||||||||||||||||||||||
| Total Adjustments | 1,160 | 2,393 | 4,103 | 5,627 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 64,515 | $ | 59,066 | $ | 213,611 | $ | 196,404 | ||||||||||||||||||
| Net income margin | 12.5 | % | 9.8 | % | 12.2 | % | 10.8 | % | ||||||||||||||||||
| Adjusted EBITDA margin | 24.8 | % | 24.2 | % | 25.6 | % | 25.4 | % | ||||||||||||||||||
| (a) | Adjustments in the nine months ended September 26, 2026 represents a $1.8 million loss incurred as a result of the Company's debt refinancing in June 2026 in connection with the entry into the Credit Agreement. The Company also incurred a $0.2 million loss on debt extinguishment as a result of the voluntary repayment of the principal balance for a portion of other bank debt in February 2026. | |||||||
| (b) | Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of Hayward’s Initial Public Offering ("IPO"). | |||||||
| (c) | Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. | |||||||
| (d) | Adjustments in the three months ended September 26, 2026 were primarily driven by $8 thousand of costs related to a restructuring action in E&RW. Adjustments in the three months ended September 27, 2025 were primarily driven by $0.3 million of costs related to restructuring actions in E&RW. | |||||||
| Adjustments in the nine months ended September 26, 2026 were primarily driven by $0.8 million of costs related to a restructuring action in E&RW and $0.5 million of termination benefits associated with the restructuring of several teams in NAM. Adjustments in the nine months ended September 27, 2025 were primarily driven by $3.3 million of transaction and integration costs associated with the acquisition of the ChlorKing business, $0.5 million of costs related to restructuring actions in E&RW and $0.2 million of separation costs for the consolidation of operations in North America, partially offset by a reduction in expense of $0.2 million to finalize the relocation of the Company's corporate office functions to Charlotte, NC from Berkeley Heights, NJ. | ||||||||
| (e) | Adjustments in the three months ended September 26, 2026 primarily included $0.2 million of non-recurring transition costs related to the restructuring in E&RW. Adjustments in the three months ended September 27, 2025 primarily included a $2.8 million non-recurring litigation expense. Expense beyond the $2.8 million was paid by the Company's insurance carriers pursuant to the Company's retention amount with its insurance carriers. Other adjustments include $0.2 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the nine months ended September 26, 2026 primarily included $0.4 million of non-recurring transition costs related to the restructuring in E&RW. Adjustments in the nine months ended September 27, 2025 primarily included a $2.8 million non-recurring litigation expense. Expense beyond the $2.8 million was paid by the Company's insurance carriers pursuant to the Company's retention amount with its insurance carriers. Other adjustments include $1.3 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. | |||||||
| (Dollars in thousands) | Last Twelve Months(f) | Fiscal Year | ||||||||||||
| September 26, 2026 | December 31, 2025 | |||||||||||||
| Net income | $ | 169,805 | $ | 151,570 | ||||||||||
| Depreciation | 23,724 | 22,835 | ||||||||||||
| Amortization | 33,311 | 34,451 | ||||||||||||
| Interest expense, net | 48,074 | 50,282 | ||||||||||||
| Income taxes | 36,022 | 33,067 | ||||||||||||
| EBITDA | 310,936 | 292,205 | ||||||||||||
Loss on debt extinguishment (a) | 2,037 | — | ||||||||||||
Stock-based compensation (b) | — | 57 | ||||||||||||
Currency exchange items (c) | 211 | 79 | ||||||||||||
Acquisition and restructuring related expense, net (d) | 1,380 | 3,886 | ||||||||||||
Other (e) | 1,922 | 3,052 | ||||||||||||
| Total Adjustments | 5,550 | 7,074 | ||||||||||||
| Adjusted EBITDA | $ | 316,486 | $ | 299,279 | ||||||||||
| Net income margin | 14.4 | % | 13.5 | % | ||||||||||
| Adjusted EBITDA margin | 26.8 | % | 26.7 | % | ||||||||||
| (a) | Adjustments in the nine months ended September 26, 2026 represents a $1.8 million loss incurred as a result of the Company's debt refinancing in June 2026 in connection with the entry into the Credit Agreement. The Company also incurred a $0.2 million loss on debt extinguishment as a result of the voluntary repayment of the principal balance for a portion of other bank debt in February 2026. | |||||||
| (b) | Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of the IPO. | |||||||
| (c) | Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. | |||||||
| (d) | Adjustments in the last 12 months ended September 26, 2026 were primarily driven by $0.8 million of costs related to restructuring actions in E&RW and $0.5 million of termination benefits associated with the restructuring of several teams in NAM. Adjustments in the year ended December 31, 2025 were primarily driven by $3.1 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, the full amount held in escrow was released to the specified key employees if such employees were employed by Hayward on the one-year anniversary of the acquisition. These payments were contingent on continued employment and were not dependent on the achievement of any metric or performance measure. The retention costs were recognized over the 12-month period from the date of acquisition. Other adjustments for the year ended December 31, 2025 included $0.4 million of costs related to restructuring actions in E&RW, $0.3 million of separation costs for the consolidation of operations in North America and $0.2 million of other acquisition and integration costs, partially offset by a reduction in expense of $0.2 million to finalize the relocation of the Company's corporate office functions to Charlotte, North Carolina from Berkeley Heights, New Jersey. | |||||||
| (e) | Adjustments in the last 12 months ended September 26, 2026 were primarily driven by $1.5 million for the settlement of the securities class action litigation. Expenses beyond the total $4.3 million recognized during Fiscal Year 2025 related to this case were paid by the Company's insurance carriers pursuant to the Company's retention amount with its insurance carriers. Other adjustments included $0.4 million of non-recurring transition costs related to the restructuring in E&RW. Adjustments in the year ended December 31, 2025 were primarily driven by $4.3 million for the settlement of the securities class action litigation as discussed above, partially offset by $1.3 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. | |||||||
| (f) | Items for the last 12 months ended September 26, 2026 were calculated by adding the items for the nine months ended September 26, 2026 plus fiscal year ended December 31, 2025 and subtracting the items for the nine months ended September 27, 2025. | |||||||
| (Dollars in thousands, except per share data) | Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
| September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |||||||||||||||||||||||
| Net income | $ | 32,419 | $ | 24,028 | $ | 101,395 | $ | 83,160 | ||||||||||||||||||
Tax adjustments (a) | (551) | (481) | (809) | (673) | ||||||||||||||||||||||
| Other adjustments and amortization: | ||||||||||||||||||||||||||
Loss on debt extinguishment (b) | — | — | 2,037 | — | ||||||||||||||||||||||
Stock-based compensation (c) | — | — | — | 57 | ||||||||||||||||||||||
Currency exchange items (d) | 949 | (536) | 368 | 236 | ||||||||||||||||||||||
Acquisition and restructuring related expense, net (e) | 8 | 276 | 1,261 | 3,767 | ||||||||||||||||||||||
Other (f) | 203 | 2,653 | 437 | 1,567 | ||||||||||||||||||||||
| Total other adjustments | 1,160 | 2,393 | 4,103 | 5,627 | ||||||||||||||||||||||
| Amortization | 8,240 | 8,642 | 24,668 | 25,808 | ||||||||||||||||||||||
Debt refinancing fees (g) | — | — | 5,186 | — | ||||||||||||||||||||||
Tax effect (h) | (2,119) | (2,708) | (7,787) | (7,717) | ||||||||||||||||||||||
| Adjusted net income | $ | 39,149 | $ | 31,874 | $ | 126,756 | $ | 106,205 | ||||||||||||||||||
| Net income margin | 12.5 | % | 9.8 | % | 12.2 | % | 10.8 | % | ||||||||||||||||||
| Adjusted net income margin | 15.0 | % | 13.0 | % | 15.2 | % | 13.7 | % | ||||||||||||||||||
| Weighted average number of common shares outstanding, basic | 212,209,178 | 216,826,626 | 215,276,635 | 216,395,032 | ||||||||||||||||||||||
| Weighted average number of common shares outstanding, diluted | 216,531,281 | 222,420,881 | 219,897,633 | 222,074,267 | ||||||||||||||||||||||
| Basic EPS | $ | 0.15 | $ | 0.11 | $ | 0.47 | $ | 0.38 | ||||||||||||||||||
| Diluted EPS | $ | 0.15 | $ | 0.11 | $ | 0.46 | $ | 0.37 | ||||||||||||||||||
| Adjusted basic EPS | $ | 0.18 | $ | 0.15 | $ | 0.59 | $ | 0.49 | ||||||||||||||||||
| Adjusted diluted EPS | $ | 0.18 | $ | 0.14 | $ | 0.58 | $ | 0.48 | ||||||||||||||||||
| (a) | Tax adjustments for the three and nine months ended September 26, 2026 reflected a normalized tax rate of 22.5% and 22.9%, respectively, compared to the Company’s effective tax rate of 21.2% and 22.3%, respectively. The Company’s effective tax rate for the three and nine months ended September 26, 2026 primarily included the tax benefits resulting from stock-based compensation and interest received on an income tax refund. Tax adjustments for the three and nine months ended September 27, 2025 reflected a normalized tax rate of 24.5% and 24.5%, respectively, compared to the Company's effective tax rate of 23.0% and 23.9%, respectively. The Company’s effective tax rate for the three and nine months ended September 27, 2025 primarily included the tax benefits resulting from stock-based compensation. | |||||||
| (b) | Adjustments in the nine months ended September 26, 2026 represents a $1.8 million loss incurred as a result of the Company's debt refinancing in June 2026 in connection with the entry into the Credit Agreement. The Company also incurred a $0.2 million loss on debt extinguishment as a result of the voluntary repayment of the principal balance for a portion of other bank debt in February 2026. | |||||||
| (c) | Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of the IPO. | |||||||
| (d) | Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. | |||||||
| (e) | Adjustments in the three months ended September 26, 2026 were primarily driven by $8 thousand of costs related to a restructuring action in E&RW. Adjustments in the three months ended September 27, 2025 were primarily driven by $0.3 million of costs related to restructuring actions in E&RW. | |||||||
| Adjustments in the nine months ended September 26, 2026 were primarily driven by $0.8 million of costs related to a restructuring action in E&RW and $0.5 million of termination benefits associated with the restructuring of several teams in NAM. Adjustments in the nine months ended September 27, 2025 were primarily driven by $3.3 million of transaction and integration costs associated with the acquisition of the ChlorKing business, $0.5 million of costs related to restructuring actions in E&RW and $0.2 million of separation costs for the consolidation of operations in North America, partially offset by a reduction in expense of $0.2 million to finalize the relocation of the Company's corporate office functions to Charlotte, NC from Berkeley Heights, NJ. | ||||||||
| (f) | Adjustments in the three months ended September 26, 2026 primarily included $0.2 million of non-recurring transition costs related to the restructuring in E&RW. Adjustments in the three months ended September 27, 2025 primarily included a $2.8 million non-recurring litigation expense. Expense beyond the $2.8 million was paid by the Company's insurance carriers pursuant to the Company's retention amount with its insurance carriers. Other adjustments include $0.2 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the nine months ended September 26, 2026 primarily included $0.4 million of non-recurring transition costs related to the restructuring in E&RW. Adjustments in the nine months ended September 27, 2025 primarily included a $2.8 million non-recurring litigation expense. Expense beyond the $2.8 million was paid by the Company's insurance carriers pursuant to the Company's retention amount with its insurance carriers. Other adjustments include $1.3 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. | |||||||
| (g) | Represents non-recurring professional fees expensed as part of our credit facility refinance for the portion of debt that was accounted for as a modification. | |||||||
| (h) | The tax effect represented the immediately preceding adjustments at the normalized tax rates as discussed in footnote (a) above. | |||||||
| (Dollars in thousands) | September 26, 2026 | December 31, 2025 | ||||||||||||
| Term Facility, due June 23, 2033 | $ | 960,000 | $ | 955,000 | ||||||||||
| Other bank debt | 1,182 | 4,826 | ||||||||||||
| Finance lease obligations | 3,715 | 3,639 | ||||||||||||
| Total Debt | $ | 964,897 | $ | 963,465 | ||||||||||
| Cash and cash equivalents | 236,250 | 329,648 | ||||||||||||
| Short-term investments | 239,186 | 69,462 | ||||||||||||
| Net Debt | $ | 489,461 | $ | 564,355 | ||||||||||
| Adjusted EBITDA | 316,486 | 299,279 | ||||||||||||
| Net Leverage | 1.5 | 1.9 | ||||||||||||
| (Dollars in thousands) | Three Months Ended | Three Months Ended | ||||||||||||||||||||||||
| September 26, 2026 | September 27, 2025 | |||||||||||||||||||||||||
| NAM | E&RW | NAM | E&RW | |||||||||||||||||||||||
| Segment income | $ | 61,782 | $ | 5,733 | $ | 55,387 | $ | 6,247 | ||||||||||||||||||
| Depreciation | 5,140 | 486 | 4,675 | 441 | ||||||||||||||||||||||
| Amortization | 1,885 | — | 1,760 | — | ||||||||||||||||||||||
Other (a) | — | 203 | (101) | — | ||||||||||||||||||||||
| Total adjustments | 7,025 | 689 | 6,334 | 441 | ||||||||||||||||||||||
| Adjusted segment income | $ | 68,807 | $ | 6,422 | $ | 61,721 | $ | 6,688 | ||||||||||||||||||
| Segment income margin | 27.3 | % | 17.0 | % | 26.6 | % | 17.3 | % | ||||||||||||||||||
| Adjusted segment income margin | 30.4 | % | 19.0 | % | 29.6 | % | 18.5 | % | ||||||||||||||||||
| (a) | Adjustments in the three months ended September 26, 2026 for E&RW primarily included $0.2 million of non-recurring transition costs related to the restructuring in E&RW. | |||||||
Adjustments in the three months ended September 27, 2025 for NAM primarily included $0.1 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. | ||||||||
| (Dollars in thousands) | Nine Months Ended | Nine Months Ended | ||||||||||||||||||||||||
| September 26, 2026 | September 27, 2025 | |||||||||||||||||||||||||
| NAM | E&RW | NAM | E&RW | |||||||||||||||||||||||
| Segment income | $ | 202,502 | $ | 20,656 | $ | 182,215 | $ | 20,374 | ||||||||||||||||||
| Depreciation | 15,147 | 1,485 | 14,623 | 1,294 | ||||||||||||||||||||||
| Amortization | 5,586 | — | 5,221 | — | ||||||||||||||||||||||
Other (a) | — | 437 | (611) | — | ||||||||||||||||||||||
| Total adjustments | 20,733 | 1,922 | 19,233 | 1,294 | ||||||||||||||||||||||
Adjusted segment income | $ | 223,235 | $ | 22,578 | $ | 201,448 | $ | 21,668 | ||||||||||||||||||
| Segment income margin | 28.4 | % | 17.2 | % | 28.0 | % | 16.7 | % | ||||||||||||||||||
Adjusted segment income margin | 31.3 | % | 18.8 | % | 31.0 | % | 17.7 | % | ||||||||||||||||||
| (a) | Adjustments in the nine months ended September 26, 2026 for E&RW primarily included $0.4 million of non-recurring transition costs related to the restructuring in E&RW. Adjustments in the nine months ended September 27, 2025 for NAM primarily included $0.6 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. | |||||||